Version:

02-04-2014 01-01-2017 02-12-2019 01-01-2022: update to the vaccination programme 01-01-2023: 2023 recommendations for routine immunisation 24-04-2024: April 2024 version

Footnotes:

1. 2023 recommendations https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/gripe_covid19/docs/RecomendacionesVacunacion_Gripe-Covid19.pdf
2. COVID-19 vaccination in children under 5 years of age is recommended only for those with high risk conditions. https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/covid19/docs/Recomendaciones_vacunacion_Otono_Invierno_Covid.pdf
3. https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/covid19/vacunasCOVID19_Profesionales.htm
4. Additional information can be found at: https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/comoTrabajamos/docs/Rotavirus_Recomendaciones2024.pdf
5. Repeat for pregnant women starting from week 27 of the pregnancy (preferably at week 27 or 28)
6. One dose at around 65 years of age if primary course completed. For additional information on catch-up vaccinations prior to 65 years of age, refer to specific recommendations available at https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/comoTrabajamos/difteria-tetanos-tosferina.htm
7. For more detail on review and recommendation for pertussis vaccination in Spain, please refer to https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/comoTrabajamos/difteria-tetanos-tosferina.htm
8. For more detail on review and recommendation for pertussis vaccination in Spain, please refer to https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/comoTrabajamos/docs/TosFerina.pdf
9. Repeat for pregnant women starting from week 27 of the pregnancy (preferably at week 27 or 28).
10. Babies born to a mother infected with hepatitis B will be offered a first dose at birth, 2, 4 and 11 months of age and HB immunoglobulin at birth (first 24 hours of life)
11. Recommended for previously unvaccinated individuals up to 18 years of age (three doses at 0, 1 and 6 months)
12. For recommendations in children and adults with high risk conditions Please refer to https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/programasDeVacunacion/riesgo/home.htm
13. For recommendations in children and adults with high risk conditions, refer to: https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/programasDeVacunacion/riesgo/home.htm
14. Additional information https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/programasDeVacunacion/docs/Vacunacion_poblacion_adulta.pdf
15. Additional information available at https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/comoTrabajamos/enf-meningococica.htm
16. One dose at 12 years to individuals who have not received any doses of MCV4 since 10 years of age. Additional information available at https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/comoTrabajamos/enf-meningococica.htm
17. The catch-up vaccination programme for individuals aged 13 to 18 years will be introduced gradually (more information available at: https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/programasDeVacunacion/adolescentes-meningo/home.htm
18. Two doses at 4 or more weeks interval recommended in individuals born in Spain since 1970 with no documented history of vaccination
19. 2 doses recommended at 4+ week-interval (preferably 8 weeks) to individuals with no documented history of disease and no documented prior vaccination (in the case of adults, vaccination is recommended if IgG serology for varicella is negative).
20. Extension of HPV vaccination to boys aged 12, applicable since October 2022. Two-dose schedule (6 months intervals between doses).
21. Previously unvaccinated girls. Three-dose schedule from 15 years of age.
22. Additional information available at https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/programasDeVacunacion/docs/Recomendaciones_vacunacion_gripe_PoblacionInfantil.pdf
23. Recommended for children and adults with high risk conditions. Additional information available: https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/programasDeVacunacion/docs/Recomendaciones_vacunacion_gripe.pdf
24. Annual vaccination
25. Recommended for adults with certain risk conditions. Two doses with a minimal interval of 2 months between doses. Vaccination with the inactivated herpes zoster subunit vaccine. Additional information available: https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/programasDeVacunacion/docs/HerpesZoster_RecomendacionesVacunacion.pdf
26. Two doses with a minimal interval of 2 months between doses. Vaccination with the inactivated herpes zoster subunit vaccine. Additional information available: https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/programasDeVacunacion/docs/HerpesZoster_RecomendacionesVacunacion.pdf

More information available at:
https://www.mscbs.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/home.htm https://www.mscbs.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/vacunas/profesionales/home.htm


Updated version including the new vaccination schedule dated December 2019


Updated version including the new vaccination schedule dated 1 jan. 2017 (modification of the primary infant and school-age immunisation schedule) applicable in all regions in Spain

For specific recommendations, please refer to:
https://www.mscbs.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/docs/CalendarioVacunacion_Todalavida.pdf

Date of last update: 24 April 2024.